Medtech Talk
Medtech Talk
Healthegy
How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera
40 minutes Posted Jul 7, 2016 at 4:00 am.
0:00
40:05
Download MP3
Show notes
The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to that favorable outcome.